Status:
COMPLETED
Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
Lead Sponsor:
Nemours Children's Clinic
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
11-17 years
Phase:
NA
Brief Summary
Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS score...
Detailed Description
This R01 responds to PAS-20-160 (Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK). Our objective is to test the feasibility, acceptability, and initial efficacy of using ...
Eligibility Criteria
Inclusion
- adolescents between 11.0-17.0 years old and their parent/guardian;
- adolescents have a physician confirmed diagnosis of type 1 diabetes of at least 6 months duration;
- adolescents use an insulin pump for daily type 1 diabetes self-management;
- adolescents evidence sub-optimal daily BOLUS scores (a mean daily BOLUS score \<2.5)
Exclusion
- adolescents who do not use an insulin pump; adolescents who have an allergy or sensitivity to the adhesive and/or skin preparation used for CGM;
- adolescents with a comorbid chronic condition (e.g., renal disease);
- adolescents and parents who do not speak English
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT05280184
Start Date
January 1 2023
End Date
September 30 2025
Last Update
December 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemours Children's Health
Jacksonville, Florida, United States, 32207
2
Children's Mercy Kansas City
Kansas City, Missouri, United States, 64108